Model
Edge
Acura Pharmaceuticals, Inc
ACUR
Filing Type
8-K
Filing Date
6/23/2025
Updated
6/24/25, 8:19 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant